ALNT Stock Analysis: Allient | NASDAQ
Electronic Components | NASDAQ, USA | Market Cap: 1.993m USD | 12M Return: 144.5% | US0193301092 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 22.6M
EPS Trend: 0.2%
Qual. Beats: 1
Rev. Trend: -29.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Allient Inc. (NASDAQ: ALNT) is a U.S.-based industrial company that designs, manufactures, and sells precision and specialty controlled motion components and systems. The company operates across the United States, Canada, South America, Europe, and the Asia-Pacific region.
Its product portfolio spans nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless and brush servo motors, torque and coreless motors, integrated motor-drives, gear motors, gearing, incremental and absolute optical encoders, and active electronic and passive magnetic filters for power quality and harmonic issues. It also offers industrial safety-rated input/output modules, universal industrial communications gateways, and light-weighting technologies.
Allient serves industrial, vehicle, medical, and aerospace and defense markets, distributing its products through a direct sales force, authorized manufacturers representatives, and distributors. The company was founded in 1939, is headquartered in Amherst, New York, and was formerly known as Allied Motion Technologies Inc. before adopting its current name in August 2023. As a small-cap stock classified within the Electrical Components & Equipment sub-industry of the industrials sector, Allient operates in a segment that supplies critical motion-control and power-quality technologies to a broad base of OEMs and end markets.
- Defense and aerospace segment revenue expands on sustained government spending
- Industrial automation demand drives precision motion component sales
- Acquisitions and integration costs pressure near-term margins
| Net Income: 28.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.78 > 1.0 |
| NWC/Revenue: 33.80% < 20% (prev 35.82%; Δ -2.02% < -1%) |
| CFO/TA 0.06 > 3% & CFO 38.4m > Net Income 28.6m |
| Net Debt (186.7m) to EBITDA (79.8m): 2.34 < 3 |
| Current Ratio: 3.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (16.9m) vs 12m ago 0.97% < -2% |
| Gross Margin: 32.24% > 18% (prev 31.49%; Δ 0.75% > 0.5%) |
| Asset Turnover: 97.26% > 50% (prev 88.36%; Δ 8.90% > 0%) |
| Interest Coverage Ratio: 3.08 > 6 (EBIT TTM 54.7m / Interest Expense TTM 17.7m) |
| A: 0.33 (Total Current Assets 274.4m - Total Current Liabilities 80.2m) / Total Assets 593.9m |
| B: 0.36 (Retained Earnings 211.6m / Total Assets 593.9m) |
| C: 0.09 (EBIT TTM 54.7m / Avg Total Assets 591.0m) |
| D: 1.11 (Book Value of Equity 312.3m / Total Liabilities 281.6m) |
| Altman-Z'' = 5.09 = AAA |
| DSRI: 1.06 (Receivables 99.8m/84.9m, Revenue 574.8m/519.6m) |
| GMI: 0.98 (GM 31.49% / 32.24%) |
| AQI: 0.94 (AQ_t 0.39 / AQ_t-1 0.42) |
| SGI: 1.11 (Revenue 574.8m / 519.6m) |
| TATA: -0.02 (NI 28.6m - CFO 38.4m) / TA 593.9m) |
| Beneish M = -2.96 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 108.63 with a total of 217,204 shares traded. Over the past week, the price has changed by -6.31%, over one month by +13.59%, over three months by +25.41% and over the past year by +144.51%.
Current recommended Stop Loss: 99.90 (which is 8% or 1.6 ATR below the current price).
Allient has received a consensus analysts rating of 4.40. Therefore, it is recommended to buy ALNT.
- StrongBuy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 118 | 8.6% |
P/E Trailing = 69.7857
P/E Forward = 33.7838
P/S = 3.4668
P/B = 6.199
Revenue TTM = 574.8m USD
EBIT TTM = 54.7m USD
EBITDA TTM = 79.8m USD
Long Term Debt = 165.9m USD (from longTermDebt, last quarter)
Short Term Debt = 5.49m USD (from shortTermDebt, last quarter)
Debt = 228.8m USD (from shortLongTermDebtTotal, last quarter) + Leases 31.7m
Net Debt = 186.7m USD (calculated: Debt 228.8m - CCE 42.1m)
Enterprise Value = 2.18b USD (1.99b + Debt 228.8m - CCE 42.1m)
Interest Coverage Ratio = 3.08 (Ebit TTM 54.7m / Interest Expense TTM 17.7m)
EV/FCF = 79.26x (Enterprise Value 2.18b / FCF TTM 27.5m)
FCF Yield = 1.26% (FCF TTM 27.5m / Enterprise Value 2.18b)
FCF Margin = 4.78% (FCF TTM 27.5m / Revenue TTM 574.8m)
Net Margin = 4.98% (Net Income TTM 28.6m / Revenue TTM 574.8m)
Gross Margin = 32.24% ((Revenue TTM 574.8m - Cost of Revenue TTM 389.5m) / Revenue TTM)
Gross Margin QoQ = 34.85% (prev 30.42%)
Tobins Q-Ratio = 3.67 (Enterprise Value 2.18b / Total Assets 593.9m)
Interest Expense / Debt = 7.76% (Interest Expense 17.7m / Debt 228.8m)
Taxrate = 22.21% (8.17m / 36.8m)
NOPAT = 42.5m (EBIT 54.7m * (1 - 22.21%))
Current Ratio = 3.42 (Total Current Assets 274.4m / Total Current Liabilities 80.2m)
Debt / Equity = 0.73 (Debt 228.8m / totalStockholderEquity, last quarter 312.3m)
Debt / EBITDA = 2.34 (Net Debt 186.7m / EBITDA 79.8m)
Debt / FCF = 6.79 (Net Debt 186.7m / FCF TTM 27.5m)
Total Stockholder Equity = 303.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.84% (Net Income 28.6m / Total Assets 593.9m)
RoE = 9.43% (Net Income TTM 28.6m / Total Stockholder Equity 303.5m)
RoCE = 11.64% (EBIT 54.7m / Capital Employed (Equity 303.5m + L.T.Debt 165.9m))
RoIC = 8.67% (NOPAT 42.5m / Invested Capital 490.5m)
WACC = 13.83% (E(1.99b)/V(2.22b) * Re(14.73%) + D(228.8m)/V(2.22b) * Rd(7.76%) * (1-Tc(0.22)))
Discount Rate = 14.73% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 98.25 | Cagr: 1.01%
[DCF] Terminal Value 55.57% ; FCFF base≈38.6m ; Y1≈33.9m ; Y5≈27.4m
[DCF] Fair Price = 2.73 (EV 233.1m - Net Debt 186.7m = Equity 46.4m / Shares 17.0m; r=13.83% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 0.16 | EPS CAGR: 0.03% | SUE: 2.11 | # QB: 1
Revenue Correlation: -29.95 | Revenue CAGR: -1.39% | SUE: 2.14 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.74 | Chg30d=+1.36% | Revisions=+40% | Analysts=5
EPS current Year (2026-12-31): EPS=2.74 | Chg30d=+0.00% | Revisions=+62% | GrowthEPS=+26.1% | GrowthRev=+8.5%
EPS next Year (2027-12-31): EPS=3.33 | Chg30d=+0.42% | Revisions=+0% | GrowthEPS=+21.8% | GrowthRev=+9.1%
[Analyst] Revisions Ratio: +58% (up=8, down=1)